During the last session, Catheter Precision Inc (AMEX:VTAK)’s traded shares were 1.53 million, with the beta value of the company hitting -0.86. The 52-week high for the VTAK share is $8.40, that puts it down -2445.45 from that peak though still a striking 51.52% gain since the share price plummeted to a 52-week low of $0.16. The company’s market capitalization is $4.11M, and the average intraday trading volume over the past 10 days was 81.99 million shares, and the average trade volume was 13.32 million shares over the past three months.

Catheter Precision Inc (AMEX:VTAK) trade information

Catheter Precision Inc (VTAK) registered a -1.92% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.92% in intraday trading to $0.33, hitting a weekly high. The stock’s 5-day price performance is -45.64%, and it has moved by 14.46% in 30 days. Based on these gigs, the overall price performance for the year is -93.99%. The short interest in Catheter Precision Inc (AMEX:VTAK) is 0.53 million shares and it means that shorts have 0.43 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 83.47%.

VTAK Dividends

Catheter Precision Inc is due to release its next quarterly earnings on 2025-May-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Catheter Precision Inc (AMEX:VTAK)’s Major holders

Catheter Precision Inc insiders own 7.99% of total outstanding shares while institutional holders control 4.67%, with the float percentage being 5.08%.